U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131475) titled 'Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure' on July 24.
Brief Summary: This is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.
Study Start Date: Sept. 04
Study Type: INTERVENTIONAL
Condition:
Blast Injury
Intervention:
DRUG: PBR28 TSPO PET
Each SEAL participant will undergo brain imaging with PBR28 translocator protein (TSPO) positron emissio...